China donates 100,000 boxes of Lianhua Qingwen to Italy
China has donated 100,000 boxes of Lianhua Qingwen — a compound of
herbal medicine that has been proved effective for treating COVID-19
patients — to Italy to help treat its patients there, experts said.
The traditional Chinese medicine, which is said to kill viruses and
remove lung heat, is suitable for clinical treatment of COVID-19
patients with a serious fever and constipation, Zhang Boli, an
academician of the Chinese Academy of Engineering and president of
Tianjin University of TCM, said on Monday at a news conference held in
Wuhan by the State Council Information Office.
After the first batch, Italy has requested for another 100,000 boxes
of the Chinese medicine, Zhang said, adding that Lianhua Qingwen was
developed during the SARS epidemic in 2003 by Wu Yiling, also an
academician of the academy.
The medicine was recommended in four versions of a treatment plan
from the National Health Commission, which noted it as an effective way
to treat COVID-19 pneumonia, according to Shijiazhuang Yiling
Pharmaceutical Co, the medicine’s maker.
More than 70 million people on the Chinese mainland have used Lianhua
Qingwen to combat influenza and the novel coronavirus pneumonia since
the outbreak, the company said.
Earlier this month, the company donated 120,000 boxes of Lianhua
Qingwen capsules, worth about 1.8 million yuan ($250,000), to Iraq
through the Red Cross Society of China, to facilitate that country’s
fighting against the virus.
A second donation to Iraq of 8,000 boxes of the medicine is being organized the company said.
Since its birth, Lianhua Qingwen has been exported to many countries
and regions, including Canada, Romania, Hungary, Brazil and Mozambique.
Since the end of February, it has received some new orders from
Shenzhen-listed Yiling Pharmaceutical is based in Shijiazhuang, Hebei province.